Virus-like particle (VLP) plus microcrystalline tyrosine (MCT) adjuvants enhance vaccine efficacy improving T and B cell immunogenicity and protection against Plasmodium berghei/vivax
Vaccination is the most effective prophylactic tool against infectious diseases. Despite continued efforts to control malaria, the disease still generally represents a significant unmet medical need. Microcrystalline tyrosine (MCT) is a well described depot used in licensed allergy immunotherapy pro...
मुख्य लेखकों: | Cabral-Miranda, G, Heath, M, Mohsen, M, Gomes, A, Engeroff, P, Flaxman, A, Leoratti, F, El-Turabi, A, Reyes-Sandoval, A, Skinner, M, Kramer, M, Bachmann, M |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
MDPI
2017
|
समान संसाधन
-
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
द्वारा: Gustavo Cabral-Miranda, और अन्य
प्रकाशित: (2017-05-01) -
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®)
द्वारा: Matthew D. Heath, और अन्य
प्रकाशित: (2020-11-01) -
Microcrystalline Tyrosine (MCT®): a depot adjuvant in licensed allergy immunotherapy offers new opportunities in malaria
द्वारा: Cabral-Miranda, G, और अन्य
प्रकाशित: (2017) -
Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria
द्वारा: Gustavo Cabral-Miranda, और अन्य
प्रकाशित: (2017-09-01) -
Evaluation of Plasmodium vivax Cell-Traversal Protein for Ookinetes and Sporozoites as a Preerythrocytic P. vivax Vaccine
द्वारा: Alves, E, और अन्य
प्रकाशित: (2017)